JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

ViewAll
Cover and Contents

Cover and Contents

Full Issue

Full Issue

Articles

https://doi.org/10.51271/JCHOR-0038

: 323 : 740

Citation : Ünal S, Yağcı AM. The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis. J Curr Hematol Oncol Res. 2024;2(3):54-58.

Original Article - Hematology

Causes of acquired isolated neutropenia in adulthood: a single center study

https://doi.org/10.51271/JCHOR-0039

: 5212 : 6130

Citation : Keklik M, Mert Yüce M, Akyol G, Mandacı Şanlı N, Çelik S, Eser B. Causes of acquired isolated neutropenia in adulthood: a single center study.J Curr Hematol Oncol Res. 2024;2(3):59-62.

Original Article - Hematology

Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation

https://doi.org/10.51271/JCHOR-0040

: 1454 : 1009

Citation : Akyol G, Keklik M, Kaynar L, Ünal A. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation. J Curr Hematol Oncol Res. 2024;2(3):63-66.

Original Article - Hematology

The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

https://doi.org/10.51271/JCHOR-0041

: 1662 : 1527

Citation : Çelik S, Erkurt MA, Sarıcı A. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience. J Curr Hematol Oncol Res. 2024;2(3):67-71.

Review - Hematology

Current status and potential future of PAI-1 inhibitors

https://doi.org/10.51271/JCHOR-0042

: 1221 : 1147

Citation : Tan T, Ağırbaşlı M. Current status and potential future of PAI-1 inhibitors. J Curr Hematol Oncol Res. 2024;2(3): 72-75.

https://doi.org/10.51271/JCHOR-0043

: 1474 : 1489

Citation : Aksöz Z. A case report of relapsed/refractory primary central nervous system lymphoma. J Curr Hematol Oncol Res. 2024; 2(3):76-78.
_Footer